| Literature DB >> 34286451 |
Thomas Gossios1,2,3, Konstantinos Savvatis4, Thomas Zegkos5, Dimitrios Ntelios5, Pavlos Rouskas5, Despoina Parcharidou5, Haralambos Karvounis5, Georgios K Efthimiadis5.
Abstract
The comprehensive assessment of patients with hypertrophic cardiomyopathy is a complex process, with each step concurrently focusing on confirmation of the diagnosis, differentiation between sarcomeric and non-sarcomeric disease (phenocopy), and prognostication. Novel modalities such as genetic testing and advanced imaging have allowed for substantial advancements in the understanding of this condition and facilitate patient management. However, their availability is at present not universal, and interpretation requires a high level of expertise. In this setting, electrocardiography, a fast and widely available method, still retains a significant role in everyday clinical assessment of this population. In our review, we follow a stepwise approach for the interpretation of each electrocardiographic segment, discussing clinical implications of electrocardiographic patterns in sarcomeric disease, their value in the differential diagnosis from phenocopies, and impact on patient management. Outlining the substantial amount of information to be obtained from a simple tracing, we exhibit how electrocardiography is likely to remain an integral diagnostic tool in the future as well.Entities:
Keywords: Arrhythmia; Cardiac hypertrophy; Electrocardiography; Hypertrophic cardiomyopathy; Myocardial fibrosis; Sudden cardiac death
Mesh:
Year: 2021 PMID: 34286451 DOI: 10.1007/s10741-021-10147-0
Source DB: PubMed Journal: Heart Fail Rev ISSN: 1382-4147 Impact factor: 4.654